| Literature DB >> 34202507 |
Abstract
Aspergillus is a genus of filamentous fungi with vast geographic and ecological distributions. Species within this genus are clinically, agriculturally and biotechnologically relevant, leading to increasing interest in elucidating gene expression dynamics of key metabolic and physiological processes. Reverse-transcription quantitative Polymerase Chain Reaction (RT-qPCR) is a sensitive and specific method of quantifying gene expression. A crucial step for comparing RT-qPCR results between strains and experimental conditions is normalisation to experimentally validated reference gene(s). In this review, we provide a critical analysis of current reference gene selection and validation practices for RT-qPCR gene expression analyses of Aspergillus. Of 90 primary research articles obtained through our PubMed query, 17 experimentally validated the reference gene(s) used. Twenty reference genes were used across the 90 studies, with beta-tubulin being the most used reference gene, followed by actin, 18S rRNA and glyceraldehyde 3-phosphate dehydrogenase. Sixteen of the 90 studies used multiple reference genes for normalisation. Failing to experimentally validate the stability of reference genes can lead to conflicting results, as was the case for four studies. Overall, our review highlights the need to experimentally validate reference genes in RT-qPCR studies of Aspergillus.Entities:
Keywords: 18S rRNA; Aspergillus; RT-qPCR; actin; aflatoxin biosynthesis; antifungal resistance; beta-tubulin; glyceraldehyde 3-phosphate dehydrogenase; reference gene; validation
Mesh:
Substances:
Year: 2021 PMID: 34202507 PMCID: PMC8307107 DOI: 10.3390/genes12070960
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Species, reference gene(s) and experimental conditions used in 90 RT-qPCR studies of Aspergillus.
| Species | Reference Gene | Validation (Y/N) | Experimental Conditions | Ref. |
|---|---|---|---|---|
|
| Actin | N | Minimal media (MM) for 3, 5 and 7 days | [ |
| Histone 3 | ||||
| GAPDH | Y | MM with 1% ( | [ | |
|
| 18S rRNA | N | Czapek-Dox Modified Yeast Agar (CYA) medium in the dark at 30 °C for 2 days | [ |
| Calmodulin | N | Co-culture with the actinobacterial strain, SN7, on International Streptomyces Project-2 (ISP2) media at 28 °C for 4 days | [ | |
| Ubiquitin-conjugating Enzyme | Y | MM at 25 °C, without shaking (ochratoxin A (OTA)-inducing conditions) for 4, 6 and 8 days in the dark | [ | |
|
| Actin | N | Cellulose membrane on malt yeast agar (MYA) and on 17% NaCl MYA media for 5 days at 28 °C in the dark, after which mycelia were fixed (extraction from 7-day mycelia) | [ |
|
| Beta-tubulin | Y | Growth on a hydrophobic polyvinylidene fluoride (PVDF) membrane on top of oatmeal agar for 3, 6 or 30 days (wildtype only) | [ |
| Histone 3 | ||||
|
| 18S rRNA | N | Glucose minimal media (GMM) containing 1% starch or 24 g/400 mL ground corn seed at 30 °C for 24, 48 and 72 h with shaking at 250 rpm | [ |
| 18S rRNA | N | Yeast extract sucrose (YES) medium at 37 °C for 1.5 days and at 28 °C for 3 days, in the dark | [ | |
| 18S rRNA | N | YES media supplemented with 0.40 mmol/L of cinnamaldehyde, 0.56 mmol/L of citral, and 0.80 mmol/L of eugenol for 7 days | [ | |
| 18S rRNA | Y | Co-culture with | [ | |
| Beta-tubulin | ||||
| Calmodulin | ||||
| Actin | N | Co-incubation with soil isolates of | [ | |
| Beta-tubulin | ||||
| Actin | N | (1) Potato dextrose agar (PDA) or GMM supplemented with NH4+ for 48 h | [ | |
| Actin | N | YES media containing 1.5 mg/100 mL silver nanoparticles at 28 °C for 14 days | [ | |
| Beta-tubulin | ||||
| Actin | N | YES or yeast peptone dextrose (YPD) media for 5 and 7 days, respectively, at 37 °C in the dark | [ | |
| Beta-tubulin | Y | Inoculated onto 25 g of wheat and grown at 30 °C in open petri dishes with wetted filter paper for 9 days | [ | |
| Beta-tubulin | N | Peanut samples for 6 weeks at 25 °C in polyethylene sandwich boxes containing glycerol/water solutions to maintain the equilibrium relative humidity conditions | [ | |
| Beta-tubulin * | N | YES or yeast extract peptone (YEP) media at 28 °C for 4 days | [ | |
| Beta-tubulin | N | Sucrose magnesium sulphate potassium nitrate yeast (SMKY) liquid media 25 °C for 7 days | [ | |
| Beta-tubulin * | N | Treatment or no treatment with the subinhibitory concentrations of carvacrol or trans-cinnamaldehyde in potato dextrose broth (PDB) at 25 °C for 5 days | [ | |
| Beta-tubulin | N | Liquid media at 30 °C with constant shaking at 120 rpm for 20 to 24 h | [ | |
| Beta-tubulin | Y | Malt extract agar (MEA) media supplemented with 0.5 mM eugenol for 4 days at 27 °C in the dark | [ | |
| GAPDH | ||||
| Beta-tubulin | N | Coconut agar at 25 °C for 2 or 7 days | [ | |
| Calmodulin | ||||
| Beta-tubulin | Y | Co-incubation with | [ | |
| GAPDH | ||||
| Beta-tubulin * | Y | YES medium containing one of four antifungal peptides: PPD1, 66-10, 77-3, or D4E1 | [ | |
| Beta-tubulin | N | PDB containing 30% ( | [ | |
|
| N | Cultures of differing water potential were supplemented with different antioxidant concentrations at 20 °C and 28 °C for 72 h | [ | |
|
| ||||
|
| 18S rRNA | Y | Treatment with 125 μg/mL artemisinin or solvent for 3 h in Roswell Park Memorial Institute (RPMI) 1640 medium at 37 °C | [ |
| 18S rRNA | N | PDA with different carbon dioxide concentrations and on Czapek media with different C: N ratios for 48 h and 5 days | [ | |
| 18S rRNA | N | Liquid | [ | |
| Actin | N | (1) GMM at 25 °C for 60 days with shaking at 280 rpm | [ | |
| Actin | N | Biofilm growth at 37 °C in minimal essential medium (MEM) supplemented with 5% | [ | |
| Actin | N | (1) CBS 144.89 and Δ | [ | |
| GAPDH | ||||
|
| ||||
| Actin | Y | Mandels’ salt solution with 1% oat spelts xylan for 0, 2, 4, 6 and 17 h | [ | |
| Histone H4 | ||||
| Actin | N | RPMI medium at 37 °C for 0, 2, 4, 6, and 8 h | [ | |
| Actin | N | Treatment with 24,700, 12,300 and 6170 µg/mL kombucha during growth in RPMI medium at 35 °C for 48 h | [ | |
| Beta-tubulin | N | Yeast extract-peptone-dextrose (YEPD) media with 10 μg/mL (H11-20) or 100 μg/mL of itraconazole for 8 h at 37 °C | [ | |
| Beta-tubulin | N | Treatment with 0.5 μg of voriconazole or without voriconazole in yeast glucose (YG) medium for 30, 60, 120, and 240 min | [ | |
| Beta-tubulin | N | AMM containing 0, 1, 10, 100, 1000 μM of FeSO4 at 37 °C for 24 h with 150 rpm shaking | [ | |
| Beta-tubulin | N | MEM supplemented with 10% ( | [ | |
| Beta-tubulin | N | Growth in mouse lung alveoli for 4 h or 14 h | [ | |
| Beta-tubulin * | N | Four formed fungi balls or 2 mL of fungal suspension in NaCl incubated for 3 h at 25, 30, 35 and 40 °C | [ | |
| Beta-tubulin * | N | Treatment with sub-lethal and lethal amphotericin B (AmB) concentrations in Sabouraud medium for 24 h at 37 °C with shaking | [ | |
| Beta-tubulin | N | Treatment with 4 mg/L itraconazole or dimethyl sulfoxide in Vogel’s medium at 37 °C with shaking at 250 rpm for 14 to 16 h | [ | |
| Beta-tubulin | N | Growth in mouse lungs subcutaneously injected with 40 mg/kg Kenalog 1 day, or intraperitoneally with 175 mg/kg of cyclophosphamide 2 days prior to inoculation | [ | |
|
| ||||
| GAPDH | N | Exposure of | [ | |
| GAPDH | N | Treatment with 10 ng/mL of itraconazole (CEA17) or 5 μg/mL of itraconazole (mutant strains) in YG medium supplemented with 1.2 g/L of uracil and uridine for 24 h at 37 °C | [ | |
| Putative 1,3-beta-glucan synthase catalytic subunit | N | Barrat’s minimal nitrate medium in the presence or absence of oxidative stress and/or iron-limitation for 33 h and 50 h | [ | |
|
| N | [ | ||
|
| N | Growth in a glucose (3%)-yeast extract (YE; 1%) liquid medium at 37 °C for 16 h | [ | |
|
| Actin | N | Growth on rice as rice koji and sampling at the stages in the process of shimaishigoto (40 °C, 30 h) and dekoji (40 h) | [ |
| Actin | N | Citric acid production (CAP) medium at 30 °C for 0 h or 12 h with shaking at 163 rpm | [ | |
|
| Actin | N | Low or high inorganic phosphate yeast extract medium (YEM) and MM at 37 °C for 17 h with shaking at 200 rpm | [ |
| Beta-tubulin | ||||
| Actin | Y | Yeast extract-agar-glucose (YAG) supplemented with 15% polyethylene glycol (PEG) ( | [ | |
| Actin | N | Complete medium (CM) or MM with inducing or non-inducing supplements at 28 °C for 16 h with 250 rpm shaking | [ | |
| Actin | N | YAG supplemented with 5 mM uridine and 10 mM uracil (YUU) at 37 °C for 24 h | [ | |
| Actin | Y | MM supplemented with 0.1% fructose and 5 mM urea at 30 °C for 15 h with shaking at 150 rpm | [ | |
| GAPDH | ||||
| Beta-tubulin | N | YG medium in the presence or absence of drugs (camptothecin, imazalil, itraconazole, hygromycin, and 4-nitroquinoline oxide) for 8 h | [ | |
| Beta-tubulin | N | 3% lactose MM for 18 h, after which a source of induction and/or repression was added, and cultures incubated for 4 h | [ | |
| Beta-tubulin | N | MM with exposure to light or darkness at 23 °C for 24 h (spores) or 30 °C for 40 h in distilled water (conidia) | [ | |
| Histone 2B | ||||
| Beta-tubulin * | N | MM supplemented with 50 mM ethyl methyl ketone or 1% glucose at 37 °C for 16 h to 18 h with shaking at 150 rpm | [ | |
| EEF-3 Elongation Factor | N | Glucose-free minimal nitrate medium or minimal nitrate medium at 37 °C for 4 h or 24 h | [ | |
| NAPDH | N | Modified MMPKRUU medium under K sufficient or deficient conditions at 37 °C for 24 h with shaking at 220 rpm | [ | |
| Putative ribosomal protein L37 | Y | Liquid MM under standard conditions | [ | |
| Putative ribosomal protein L3 | ||||
|
| 18S rRNA | N | PDA supplemented with different carbon and nitrogen sources | [ |
| 18S rRNA * | N | Subculturing of transformants in the presence of 1.25 mg/mL of 5-fluoroorotic acid with uridine and uracil | [ | |
| Actin | N | Liquid AMM for 0, 3, 6, 12 and 72 h and on AMM plates for 5 days | [ | |
| Actin | N | Liquefied corn starch medium at 35 °C for 72 h with shaking at 330 rpm | [ | |
| GAPDH | ||||
| Actin | N | CM for 25 h | [ | |
| GAPDH | N | Glucose maltose polypeptone yeast extract (GMPY) media at 30 °C and 250 rpm for 2 days | [ | |
| Histone H2B | N | MM supplemented with L-rhamnose or L-rhamnonate at 30 °C with shaking at 250 rpm | [ | |
| Histone-encoding Gene | Y | Growth in bioreactors on sorbitol as the carbon source with 1 mM D-xylose or 50 mM D-xylose | [ | |
|
| Calmodulin | N | Coconut agar at 25, 30 and 35 °C for 7 days | [ |
|
| 18S rRNA * | N | Subculturing of transformants in the presence of 1.25 mg/mL of 5-fluoroorotic acid with uridine and uracil | [ |
| Actin | N | MM whole culture broth grown on a cellulose nitrate filter for 42 to 48 h until pigmented conidiospores present | [ | |
| Actin | N | DPY agar medium for 48 h | [ | |
| Actin | N | PDA medium at 30 °C for 7 days | [ | |
| Beta-tubulin | N | Modified Czapek–Dox (CD) minimal agar at 30 °C for 48 h with 200 rpm shaking | [ | |
| Beta-tubulin * | N | (1) α-amylase transcripts: Inducing (1% sorbitol plus 1% starch), non-inducing (1% sorbitol), and repressing (1% sorbitol plus 1% starch plus 2% sucrose) conditions for 48 h | [ | |
| Histone H1 | N | Growth on 5 g of wheat bran containing 2, 3, 4, 6 or 8 mL of water at 30 °C for 48 h | [ | |
| Histone H1 | N | MM at 30 °C for 5 days | [ | |
| Histone H2A | N | DPY liquid medium at 30 °C for 2 days | [ | |
|
| 18S rRNA * | N | Adye and Mateles (1964) medium for 48 h and 72 h | [ |
| 18S rRNA | N | Stationary phase culture growth in PDB 30 °C for 4 days in the dark | [ | |
| Actin | Y | Treatment with 0, 0.25, 0.5 or l.0 μg/mL aflastatin A for 1.5 to 3.5 days in PDB at 27 °C | [ | |
| Actin | N | RPMI medium containing 25 or 50 mg/mL of vitamin C for 3 days at 28 °C | [ | |
| Actin | Y | Co-incubation with | [ | |
| Beta-tubulin * | N | YES or YEP media at 28 °C for 4 days | [ | |
| Beta-tubulin | N | Yeast extract sucrose peptone (YESP) medium modified with 1% sodium nitrate (YESP-N) or 1% tryptophan (YESP-T) at 10, 15, 25, 30 and 37 °C for 96 h with shaking at 100 rpm | [ | |
| Beta-tubulin * | N | Treatment or no treatment with the subinhibitory concentrations of carvacrol or trans-cinnamaldehyde in PDB at 25 °C for 5 days | [ | |
| Beta-tubulin * | Y | YES medium containing one of four antifungal peptides: PPD1, 66-10, 77-3, or D4E1 | [ | |
|
| 18S rRNA * | N | Adye and Mateles (1964) medium for 48 h and 72 h | [ |
|
| Actin | Y | Lovastatin production media at 27 °C for 10 days with shaking at 220 rpm | [ |
| Actin | N | MID medium for 10 days after which 0.5, 1.0, 3.0 and 5.0% ( | [ | |
| Beta-tubulin * | N | Four formed fungi balls or 2 mL of fungal suspension in NaCl incubated for 3 h at 25, 30, 35 and 40 °C | [ | |
| Beta-tubulin * | N | Treatment with sublethal and lethal concentrations of AmB in Sabouraud media at 37 °C for 24 h with slight shaking | [ | |
|
| Beta-tubulin | N | CYA in the presence or absence of | [ |
| GAPDH | N | YES medium at 25 °C for 96 h | [ |
Y, validation was provided; *, analysed more than one species of Aspergillus and appear twice in the table.
Figure 1Distribution of reference gene usage across 90 RT-qPCR studies of Aspergillus. Note that in the 90 studies examined, reference genes were used a total of 108 times, as some studies used multiple reference genes. Therefore, 108 was used as the denominator when computing the frequency of reference gene usage. The group “other” is comprised of reference genes that were used fewer than four times. Beta-tubulin was the most frequently used reference genes, at 31 times in the literature.
Recommended reference genes for specific species and experimental conditions based on experimental validation.
| Species | Reference Gene | Forward Primer (5′-3′) | Reverse Primer (5′-3′) | Experimental Conditions | Ref. |
|---|---|---|---|---|---|
|
| GAPDH | TACCGCTGCCCAGAACATCA | GGAGTGGCTGTCACCGTTCA | Minimal media (MM) with 1% ( | [ |
|
| Ubiquitin-conjugating Enzyme | CCGAAGGTCAACTTCACCAC | GGCATATTTGCGAGTCCATT | MM at 25 °C, without shaking (ochratoxin A (OTA)-inducing) conditions, for 4, 6 and 8 days in the dark | [ |
|
| Beta-tubulin | GCTCTTCCGTCCCGATAACTT | CCTTGGCCCAGTTGTTACCA | Growth on a hydrophobic polyvinylidene fluoride (PVDF) membrane on top of oatmeal agar for 3, 6 or 30 days (wildtype only) | [ |
| Histone 3 | CAAGAAGCCTCACCGCTACAAG | GACTTCTGGTAGCGACGGATTT | |||
|
| 18S rRNA | GCAAATTACCCAATCCCGACAC | GAATTACCGCGGCTGCTG | Co-culture with | [ |
| Beta-tubulin | CGCATGAACGTCTACTTCAACGAG | AGTTGTTACCAGCAGCGGACT | |||
| Calmodulin | CTTCCCCGAATTCCTTACC | TCACGGATCATCTCATCGAC | |||
| Beta-tubulin | CTTGTTGACCAGGTTGTCGAT * | GTCGCAGCCCTCAGCCT* | Inoculated onto 25 g of wheat and grown at 30 °C in open petri dishes with wetted filter paper for 9 days | [ | |
| Beta-tubulin | AACGTCTACTTCAACGAGGCCA | GTACCAGGCTCAAGATCAACGAG | Malt extract agar (MEA) media supplemented with 0.5 mM eugenol for 4 days at 27 °C in the dark | [ | |
| GAPDH | CGTGTTGTTGACCTCATTGCCT | GGTGACCTGATAATCCGGGAAC | |||
| Beta-tubulin | AACGTCTACTTCAACGAGGCCA | GTACCAGGCTCAAGATCAACGAG | Co-incubation with | [ | |
| GAPDH | CGTGTTGTTGACCTCATTGCCT | GGTGACCTGATAATCCGGGAAC | |||
| Beta-tubulin | TCTCCAAGATCCGTGAGGAG | TTCAGGTCACCGTAAGAGGG | Yeast extract sucrose (YES) medium containing one of four antifungal peptides: PPD1, 66-10, 77-3, or D4E1 | [ | |
| Cytochrome C oxidase Subunit V | CGTCATTCACTTGTTCGCTAAG | CCTTGGCATACTCGTTGGAAG | Sucrose low salts (SLS), SLS supplemented with 117 mM ammonium sulphate, and lactose low salts, at acidic or alkaline pH | [ | |
| Histone H4 | TCGTCGTGGTGGTGTCAAG | TTGGCGTGCTCAGTGTAGG | |||
|
| 18S rRNA | TCTTGTTAAACCCTGTCGTGCTGG | GTGTACAAAGGGCAGGGACGTAAT | Treatment with 125 μg/mL artemisinin or solvent for 3 h in Roswell Park Memorial Institute (RPMI) 1640 medium at 37 °C | [ |
| Actin | TGCCCTTGCTCCCTCGTCTA | ACCGCTCTCGTCGTACTCCT | Mandels’ salt solution with 1% oat spelts xylan for 0, 2, 4, 6 and 17 h | [ | |
| Histone H4 | GCTCGTCGTGGTGGTGTCAA | TGGCGTGCTCAGTGTAGGTG | |||
|
| Actin | TCAATCCCAAGTCCAACC (Tm 57 °C) | TACGACCGGAAGCATACA (Tm 57 °C) | Yeast extract-agar-glucose (YAG) supplemented with 15% polyethylene glycol (PEG) ( | [ |
| AATGGTTCGGGTATGTGC (Tm 60 °C) | ACGCTTGGACTGTGCCTC (Tm 60 °C) | ||||
| Actin-like protein | GTACGATGAGAGCGGTCCTT | CAGAAAATACGCGACAACGA | MM supplemented with 0.1% fructose and 5 mM urea at 30 °C for 15 h with shaking at 150 rpm | [ | |
| GAPDH | CGACAACGAGTGGGGTTACT | GGCATCAACCTTGGAGATGT | |||
| Calmodulin | CCGAGTACAAGGAAGCTTTCTC | GAATCATCTCGTCGACTTCGTCGTCAGT | WB/MM supplemented with high, low or no iron for 24, 48 and 72 h | [ | |
| Putative ribosomal protein L3 | TTCCTCGCAAGACTCACAAG | TTGTGGTTGCAAGAGGTACG | Liquid MM under standard conditions | [ | |
| Putative ribosomal protein L37 | CGCCACAACAAAACTCACAC | TCTCGCTCCAGTTGTACTTGC | |||
|
| Actin | GGTCTGGAGAGCGGTGGTAT | cactgcGAAGAAGGAGCAAGAGCAGtG | [ | |
| Cytochrome C oxidase Subunit V | GACCAAGGAGTGGCAGGAG | gaactgGGTGGGAGGCAGCAGtTC | |||
| Secretion Associated Binding Protein | gaacctACGGGTAAGGGCAAGGtTC | TCGCAACAATAAAGTCAACAGC | |||
| Histone-encoding Gene | ATCTTGCGTGACAACATCCA | CACCCTCAAGGAAGGTCTTG | Growth in bioreactors on sorbitol as the carbon source with 1 mM D-xylose or 50 mM D-xylose | [ | |
|
| Actin | CTTGACTTCGAGCAGGAGAT | TCTGGATACGGTCGGAGATA | Treatment with or without 1.0 μM of blasticidin A in potato dextrose broth (PDB) at 27 °C for 2 days | [ |
| Actin | CGCGGATACACCTTCTCCACTA * | ACGTAGCAGAGCTTCTCCTTGA * | Treatment with 0, 0.25, 0.5 or l.0 μg/mL aflastatin A for 1.5 to 3.5 days in PDB at 27 °C | [ | |
| Actin | NA | NA | Co-incubation with | [ | |
| Beta-tubulin | TCTCCAAGATCCGTGAGGAG | TTCAGGTCACCGTAAGAGGG | YES medium containing one of four antifungal peptides: PPD1, 66-10, 77-3, or D4E1 | [ | |
|
| Actin | TCGTGACTTGACCGACTACC | TGATGTCACGGACGATTTCA | Lovastatin production media at 27 °C for 10 days with shaking at 220 rpm | [ |
*, used TaqMan system and therefore these primers have an associated probe, NA, not available.
Figure 2Number of search results for each reference gene based on their corresponding Google Scholar query. The 18S rRNA reference gene returned the most results, with 3290 results returned.
Figure 3Recommended checkpoints to use when selecting reference genes.